Krystal Biotech Inc (KRYS)

R&D Expense Growth

-5.30%

Quarterly · Period ending:

KRYS logo

KRYS R&D Expense Growth

Latest reported-5.30%
KRYS Quarterly R&D Growth (QoQ) (0.00% → -5.30%)
High-resolution chart · PNG

KRYS r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Krystal Biotech Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-5.303%
-5.335%
22.829%
-8.501%
1.0873%
5.413%
0.0888%
-13.2965%
42.2196%
-3.6324%
6.9715%
-12.4753%
-1.1719%
14.4028%
-6.7298%
5.7484%
23.023%
-1.7427%
48.1743%
-7.795%
6.3377%
9.3265%
11.2157%
40.1484%
3.234%
-18.9469%
11.9434%
-7.851%
33.1228%
13.0264%
46.395%
25.5082%
0.3289%
39.7059%
-19.7048%
203.8117%
39.8119%
-20.6468%
66.805%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.